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Background
Comparative analyses of synovitis in spondyloarthritis
(SpA) versus rheumatoid arthritis (RA) suggested that
the innate immune system may play a predominant role
in SpA pathogenesis. Based on our recent observation of
marked synovial mast cell infiltration in psoriatic arthritis
(PsA), we aimed to investigate the potential contribution
of mast cells to synovial inflammation in SpA.
Methods
Synovial tissue and fluid were obtained in non-psoriatic
and psoriatic SpA and RA patients. Synovial tissue was
analyzed by immunohistochemistry and double immuno-
fluorescence. Synovial fluid was analyzed by ELISA. Syno-
vial tissue biopsies were used for ex vivo cultures.
Results
In comparison with RA, synovial infiltration with C-kit
positive mast cells was strongly and specifically increased
in SpA, independently of the subtype (non-psoriatic versus
psoriatic) and disease duration. Staining of mast cell gran-
ules with tryptase and toluidine blue as well as analysis of
synovial fluid levels of histamine and tryptase did not indi-
cate increased degranulation in SpA synovitis. Mast cells
expressed significantly more IL-17 in SpA than RA synovi-
tis and constituted the major IL-17 expressing cell popula-
tion in SpA synovitis. Targeting mast cells with the c-kit
inhibitor imatinib mesylate in ex vivo tissue cultures led to
a significant decrease in the production of IL-17 as well as
other pro-inflammatory cytokines. To confirm that mast
cell infiltration is not a merely secondary, inflammation-
dependent feature of SpA, we assessed the impact of TNF
blockade on mast cell infiltration in vivo. Analysis of
paired synovial biopsies before and after treatment
revealed that neither the number of mast cells nor the
expression of IL-17 by mast cells was affected by effective
TNF blockade in SpA.
Conclusion
The specific increase of IL-17 expressing mast cell num-
bers in SpA synovitis and the ex vivo targeting of these
cells indicate that the mast cell/IL17 axis may contribute
to the synovial inflammation in peripheral SpA. The mast
cells/IL-17 axis is not affected by effective TNF blockade.
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